Diebold Nixdorf (DBD) Misses Q3 EPS by 17c, Offers FY Guidance
Tweet
Share
E-mail
Get Alerts DBD Hot Sheet
Price: $31.93 -0.41%
EPS Growth %: +191.8%
Financial Fact:
Net income attributable to Diebold, Incorporated: -0.32
Today's EPS Names:
MAXN, CSTR, ACU, More
EPS Growth %: +191.8%
Financial Fact:
Net income attributable to Diebold, Incorporated: -0.32
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Diebold Nixdorf (NYSE: DBD) reported Q3 EPS of $0.34, $0.17 worse than the analyst estimate of $0.51. Revenue for the quarter came in at $958.2 million versus the consensus estimate of $1.04 billion.
GUIDANCE:
Diebold Nixdorf sees FY2021 revenue of $3.9-3.95 billion, versus the consensus of $4.06 billion.
For earnings history and earnings-related data on Diebold Nixdorf (DBD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Procter & Gamble (PG) Tops Q3 EPS by 11c, Revenues Miss
- BancFirst Corp. (BANF) Tops Q1 EPS by 11c
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
